ABVC - ABVC BioPharma, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
2.93 0.01 (0.34%) --- --- 0.01 (0.34%) 0.1 (3.41%) -0.09 (-2.97%) 0.0 (0.0%) 0.0 (0.0%)

ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.06
Diluted EPS:
-0.06
Basic P/E:
-49.0
Diluted P/E:
-49.0
RSI(14) 1m:
0.0
VWAP:
2.94
RVol:
0.2203

Events

Period Kind Movement Occurred At
1m Price increase 1m 2.99 +0.06 (+2.05%) Oct 15 13:00
1m Price increase 1m 3.03 +0.1 (+3.41%) Oct 15 09:03
10m Price increase 10m 3.03 +0.1 (+3.41%) Oct 15 09:03

Related News